| Ziyi Sun,Yuan Chen. Updates in the management of brain (leptomeningeal) metastasis of lung cancer. Oncol Transl Med, 2018, 4: 144-150. |
| Updates in the management of brain (leptomeningeal) metastasis of lung cancer |
| Received:May 07, 2018 Revised:August 06, 2018 |
| View Full Text View/Add Comment Download reader |
| KeyWord:brain (leptomeningeal) metastasis; non-small cell lung cancer (NSCLC); chemotherapy; epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI); whole brain radiotherapy (WBRT) |
| Author Name | Affiliation | E-mail | | Ziyi Sun | Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China | 26877345@qq.com | | Yuan Chen | Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China | chenyuan008@163.com |
|
| Hits: 5596 |
| Download times: 6953 |
| Abstract: |
| Brain (leptomeningeal) metastasis is one of the most common and severe complications of lung cancer.
This article interprets expert consensus on the treatment advice for brain (leptomeningeal) metastasis of
lung cancer, expounding on its epidemiology, diagnostic standards, efficacy assessment, treatment advice,
and other aspects. |
| Close |
|
|
|